
IGF-1 LR3 1mg arrived with clear documentation, intact packaging and a batch-specific COA that made internal receipt checks straightforward.

| Tesamorelin | |
| CAS Number | 901758-09-6 |
| Molar Mass | 5146 g/mol |
| Molecular Formula | C221H366N72O67S |
| Sequence | Unk-Tyr-Ala-Asp-Ala-xiIle-Phe-xiThr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-xiIle-Met-Ser-Arg-Gln-Gln-Gly-Gln-Ser-Asn-Gln-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
Tesamorelin is a synthetic peptide that mimics the growth hormone-releasing hormone (GHRH) naturally produced by the hypothalamus in the brain. With a molecular weight of 5146 g/mol, Tesamorelin was developed by Theratechnologies, a company based in Montreal, Canada, specifically to address lipodystrophy—a common condition among HIV-infected individuals.In November 2010, the FDA approved Tesamorelin for the treatment of HIV-associated lipodystrophy. Clinical trials have demonstrated that Tesamorelin significantly reduces waist circumference and visceral adipose tissue (VAT) after 26 weeks of treatment. Extension phases of these trials confirmed that the improvements in VAT were maintained over time.
In a 2014 clinical trial, Tesamorelin administered for 6 months was associated with reductions in visceral fat and additionally with modest reductions in liver fat.
Important Reminder:
Before reconstitution, ensure both the peptide and bacteriostatic mixing water are at room temperature to support proper dissolution and avoid destabilising the compound.
Bacteriostatic mixing water sold separately.
Disclaimer:
Disclaimer:
All products featured on this site are intended solely for research purposes and are not for human or animal consumption under any circumstances. These items should not be classified as drugs, foods, cosmetics, or medicinal products. By purchasing, the buyer assumes all associated risks and agrees to handle the products only as specified. Products should be administered by qualified professionals with the relevant expertise.
The distributor, manufacturer, and seller bear no responsibility for any misuse or subsequent outcomes arising from the use of these products. By completing and paying for your order, you agree to our Terms and Conditions and acknowledge that you will abide by these terms.

IGF-1 LR3 1mg arrived with clear documentation, intact packaging and a batch-specific COA that made internal receipt checks straightforward.

AOD 9604 5mg was dispatched quickly and the labeling was precise. The published test data matched what our team expected from a research supplier.

AOD 9604 10mg was easy to verify against the listed batch information. Clean presentation, responsive support and smooth EU delivery.

Thymosin Alpha 1 10mg came with the level of traceability we need. The online certificate and packaging consistency were both very good.

Thymosin Alpha 1 Nasal Spray 10mg was packed securely and delivered on time. Useful product page details and a professional overall process.

GLOW 70mg pen order was handled efficiently and the quality paperwork was easy to review before purchase.

Selank Nasal Spray 10mg arrived with clear instructions and careful packing. The experience felt well organized from checkout to delivery.

Semax Nasal Spray 10mg was exactly as described. Strong communication, fast processing and transparent product documentation.

Our Berlin team ordered IGF-1 LR3 1mg and the process was excellent from checkout to delivery. The batch data was easy to review and the packaging arrived in very professional condition.
| Tesamorelin | |
| CAS Number | 901758-09-6 |
| Molar Mass | 5146 g/mol |
| Molecular Formula | C221H366N72O67S |
| Sequence | Unk-Tyr-Ala-Asp-Ala-xiIle-Phe-xiThr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-xiIle-Met-Ser-Arg-Gln-Gln-Gly-Gln-Ser-Asn-Gln-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
Tesamorelin is a synthetic peptide that mimics the growth hormone-releasing hormone (GHRH) naturally produced by the hypothalamus in the brain. With a molecular weight of 5146 g/mol, Tesamorelin was developed by Theratechnologies, a company based in Montreal, Canada, specifically to address lipodystrophy—a common condition among HIV-infected individuals.In November 2010, the FDA approved Tesamorelin for the treatment of HIV-associated lipodystrophy. Clinical trials have demonstrated that Tesamorelin significantly reduces waist circumference and visceral adipose tissue (VAT) after 26 weeks of treatment. Extension phases of these trials confirmed that the improvements in VAT were maintained over time.
In a 2014 clinical trial, Tesamorelin administered for 6 months was associated with reductions in visceral fat and additionally with modest reductions in liver fat.
Important Reminder:
Before reconstitution, ensure both the peptide and bacteriostatic mixing water are at room temperature to support proper dissolution and avoid destabilising the compound.
Bacteriostatic mixing water sold separately.
Disclaimer:
Disclaimer:
All products featured on this site are intended solely for research purposes and are not for human or animal consumption under any circumstances. These items should not be classified as drugs, foods, cosmetics, or medicinal products. By purchasing, the buyer assumes all associated risks and agrees to handle the products only as specified. Products should be administered by qualified professionals with the relevant expertise.
The distributor, manufacturer, and seller bear no responsibility for any misuse or subsequent outcomes arising from the use of these products. By completing and paying for your order, you agree to our Terms and Conditions and acknowledge that you will abide by these terms.
54.99 €
{Research Peptides Europe}
Typically replies within minutes
Thanks for contacting Research Peptides Europe
How can we help you today ?
WhatsApp Us
🟢 Online | Privacy policy
WhatsApp us